ARKG vs. ARKX
ARKG (ARK Genomic Revolution Multi-Sector ETF) and ARKX (ARK Space Exploration & Innovation ETF) are both exchange-traded funds - ARKG is a Health & Biotech Equities fund actively managed by ARK, while ARKX is a Aerospace & Defense fund actively managed by ARK. Both are actively managed. Over the past 5 years, ARKG returned -15.72%/yr vs 11.53%/yr for ARKX. A 0.72 correlation means they provide meaningful diversification when combined. Both charge a 0.75% expense ratio.
Performance
ARKG vs. ARKX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARKG achieves a 17.09% return, which is significantly lower than ARKX's 23.67% return.
ARKG
- 1D
- -0.24%
- 1M
- 10.92%
- YTD
- 17.09%
- 6M
- 10.02%
- 1Y
- 53.35%
- 3Y*
- 0.67%
- 5Y*
- -15.72%
- 10Y*
- 7.22%
ARKX
- 1D
- -2.24%
- 1M
- 10.24%
- YTD
- 23.67%
- 6M
- 28.83%
- 1Y
- 69.46%
- 3Y*
- 36.41%
- 5Y*
- 11.53%
- 10Y*
- —
ARKG vs. ARKX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 17.09% | 23.04% | -28.24% | 16.22% | -53.90% | -27.00% |
ARKX ARK Space Exploration & Innovation ETF | 23.67% | 48.46% | 26.67% | 24.37% | -34.27% | -7.14% |
Correlation
The correlation between ARKG and ARKX is 0.60, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.60 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.67 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.72 |
Correlation (All Time) Calculated using the full available price history since Mar 31, 2021 | 0.72 |
The correlation between ARKG and ARKX shifts across timeframes, from 0.60 (1 year) to 0.72 (5 years), reflecting how their relationship changes across market environments.
ARKG vs. ARKX - Sectors Allocation Comparison
Sectors
ARKG
ARKX
Healthcare
Financial Services
-
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
Real Estate
-
-
Technology
-
Utilities
-
-
Healthcare
ARKG
ARKX
Financial Services
ARKG
ARKX
-
Basic Materials
ARKG
-
ARKX
Communication Services
ARKG
-
ARKX
Consumer Cyclical
ARKG
-
ARKX
Consumer Defensive
ARKG
-
ARKX
-
Energy
ARKG
-
ARKX
-
Industrials
ARKG
-
ARKX
Real Estate
ARKG
-
ARKX
-
Technology
ARKG
-
ARKX
Utilities
ARKG
-
ARKX
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARKG vs. ARKX — Risk / Return Rank
ARKG
ARKX
ARKG vs. ARKX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and ARK Space Exploration & Innovation ETF (ARKX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ARKG | ARKX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.84 | ||
| Sortino ratioReturn per unit of downside risk | -0.76 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.33 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | 1.95 | 3.42 | -1.47 |
| Martin ratioReturn relative to average drawdown | 4.67 | 9.20 | -4.54 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ARKG | ARKX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.31 | 2.15 | -0.84 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.35 | 0.42 | -0.76 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.18 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.13 | 0.43 | -0.29 |
Drawdowns
ARKG vs. ARKX - Drawdown Comparison
The maximum ARKG drawdown since its inception was -83.59%, which is greater than ARKX's maximum drawdown of -43.61%. Use the drawdown chart below to compare losses from any high point for ARKG and ARKX.
Loading charts...
Drawdown Indicators
| ARKG | ARKX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.59% | -43.61% | -39.98% |
Max Drawdown (1Y)Largest decline over 1 year | -27.51% | -20.42% | -7.09% |
Max Drawdown (3Y)Largest decline over 3 years | -51.96% | -25.47% | -26.49% |
Max Drawdown (5Y)Largest decline over 5 years | -80.18% | -43.61% | -36.57% |
Max Drawdown (10Y)Largest decline over 10 years | -83.59% | — | — |
Current DrawdownCurrent decline from peak | -69.65% | -5.03% | -64.62% |
Average DrawdownAverage peak-to-trough decline | -35.87% | -19.99% | -15.88% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.46% | 7.57% | +3.89% |
Volatility
ARKG vs. ARKX - Volatility Comparison
ARK Genomic Revolution Multi-Sector ETF (ARKG) has a higher volatility of 11.90% compared to ARK Space Exploration & Innovation ETF (ARKX) at 11.01%. This indicates that ARKG's price experiences larger fluctuations and is considered to be riskier than ARKX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARKG | ARKX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.90% | 11.01% | +0.89% |
Volatility (6M)Calculated over the trailing 6-month period | 28.77% | 25.01% | +3.76% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.12% | 32.49% | +8.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.61% | 27.72% | +17.89% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.12% | 27.42% | +13.70% |
ARKG vs. ARKX - Expense Ratio Comparison
Both ARKG and ARKX have an expense ratio of 0.75%.
Dividends
ARKG vs. ARKX - Dividend Comparison
Neither ARKG nor ARKX has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% |
ARKX ARK Space Exploration & Innovation ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
ARKG and ARKX have a correlation of 0.60, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKG has higher volatility (11.90%) compared to ARKX (11.01%). In terms of maximum drawdown, ARKG dropped -83.59% vs ARKX's -43.61%.
On 5-year performance, ARKX leads with 11.53% vs -15.72% for ARKG. Both ETFs have the same 0.75% expense ratio. On volatility, ARKX has been the lower-risk option at 11.01%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, ARKX has performed better with a 11.53% return vs -15.72%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
ARKG and ARKX have the same expense ratio: 0.75% per year.
ARKG and ARKX have nearly identical dividend yields, around 0.00%.
ARKG is categorized as Health & Biotech Equities, while ARKX is Aerospace & Defense.
ARKX currently has the higher Sharpe Ratio (2.15 vs 1.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARKG and ARKX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer